chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain
Clinical narrative: feeling pain around the injection site; pain in whole part of her shoulder.; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (feeling pain around the injection site) and ARTHRALGIA (pain in whole part of her shoulder.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced INJECTION SITE PAIN (feeling pain around the injection site) and ARTHRALGIA (pain in whole part of her shoulder.). At the time of the report, INJECTION SITE PAIN (feeling pain around the injection site) and ARTHRALGIA (pain in whole part of her shoulder.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information provided. No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Testicular itching; testicular redness; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Testicular itching) and ERYTHEMA (testicular redness) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PRURITUS (Testicular itching) and ERYTHEMA (testicular redness). At the time of the report, PRURITUS (Testicular itching) and ERYTHEMA (testicular redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Symptoms were getting progressively worse; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Symptoms were getting progressively worse) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M208) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced ADVERSE EVENT (Symptoms were getting progressively worse). At the time of the report, ADVERSE EVENT (Symptoms were getting progressively worse) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pruritus, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Warm to the touch; Redness; Swelling; Soreness, tenderness; Headache; Itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Soreness, tenderness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PRURITUS (Itching). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE PAIN (Soreness, tenderness) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. On 22-Feb-2021, PRURITUS (Itching) had resolved. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE PAIN (Soreness, tenderness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Warm to the touch; Redness; Swelling; Soreness, tenderness; Headache; Itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Soreness, tenderness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PRURITUS (Itching). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE PAIN (Soreness, tenderness) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. On 22-Feb-2021, PRURITUS (Itching) had resolved. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE PAIN (Soreness, tenderness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pre-existing condition improved, Vaccination site pain
Clinical narrative: cured from chronic pain; Soreness at the injection site; This spontaneous case was reported by a physician and describes the occurrence of PRE-EXISTING CONDITION IMPROVED (cured from chronic pain) and VACCINATION SITE PAIN (Soreness at the injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chronic pain, Facial pain, Myalgia and Hip injury. Concomitant products included VITAMINS NOS, CALCIUM, ESCITALOPRAM OXALATE (LEXAPRO), HYDROCODONE and HYDROCODONE BITARTRATE, IBUPROFEN (VICOPROFEN) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). On 07-Feb-2021, the patient experienced PRE-EXISTING CONDITION IMPROVED (cured from chronic pain). At the time of the report, PRE-EXISTING CONDITION IMPROVED (cured from chronic pain) and VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Formication, Hypoaesthesia, Paraesthesia
Clinical narrative: tingling; Numbness on right back shoulder, also started from hip down to toes; feels like ant crawling down my body; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (tingling), HYPOAESTHESIA (Numbness on right back shoulder, also started from hip down to toes) and FORMICATION (feels like ant crawling down my body) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PARAESTHESIA (tingling), HYPOAESTHESIA (Numbness on right back shoulder, also started from hip down to toes) and FORMICATION (feels like ant crawling down my body). At the time of the report, PARAESTHESIA (tingling), HYPOAESTHESIA (Numbness on right back shoulder, also started from hip down to toes) and FORMICATION (feels like ant crawling down my body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was provided. No treatment was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Toothache
Clinical narrative: teeth started to hurt AND teeth feel achy; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (teeth started to hurt AND teeth feel achy) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A20A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, BUPROPION HYDROCHLORIDE (WELLBUTRIN), GABAPENTIN, MIRABEGRON, DULOXETINE, MULTIVITAMIN [VITAMINS NOS] and VITAMIN B COMPLEX (B COMPLEX [VITAMIN B COMPLEX]) for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced TOOTHACHE (teeth started to hurt AND teeth feel achy). At the time of the report, TOOTHACHE (teeth started to hurt AND teeth feel achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Pyrexia
Clinical narrative: sore arm; fever; body aches; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (sore arm), PYREXIA (fever) and MYALGIA (body aches) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PYREXIA (fever) and MYALGIA (body aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), PYREXIA (fever) and MYALGIA (body aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Right arm was a little bit sore; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Right arm was a little bit sore) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Reflux gastritis. Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (HYZAAR) for Blood pressure high, OMEPRAZOLE for Reflux gastritis.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 09-Jan-2021, the patient experienced PAIN IN EXTREMITY (Right arm was a little bit sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Right arm was a little bit sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Nausea, Pain, Pyrexia
Clinical narrative: Aching whole body; Chills; Nausea; Fever; Feeling cold; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aching whole body), FEELING COLD (Feeling cold), CHILLS (Chills), NAUSEA (Nausea) and PYREXIA (Fever) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included SIMVASTATIN, AMLODIPINE BESILATE, VALSARTAN (ASARTAN), CETOMACROGOL, PARAFFIN, LIQUID, PROPYLENE GLYCOL, WHITE SOFT PARAFFIN (VASELINE CETOMACROGOL CREAM), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), LEVOTHYROXINE SODIUM (LEVOTIROXIN), LOSARTAN, PANTOPRAZOLE and FISH OIL for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced FEELING COLD (Feeling cold). On 22-Jan-2021, the patient experienced PAIN (Aching whole body), CHILLS (Chills), NAUSEA (Nausea) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 25-Jan-2021, PAIN (Aching whole body), FEELING COLD (Feeling cold), CHILLS (Chills), NAUSEA (Nausea) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Pyrexia: 100.2 Farad (High) 100.2°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant med also include  "Naleda" 10mg daily,
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Influenza like illness, Nausea, Pain
Clinical narrative: arm pain; total body aches; flu like symptoms; fever; nausea; joint aches; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (arm pain), PAIN (total body aches), INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever) and NAUSEA (nausea) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain), PAIN (total body aches), INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever), NAUSEA (nausea) and ARTHRALGIA (joint aches). At the time of the report, PAIN IN EXTREMITY (arm pain), PAIN (total body aches), INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever), NAUSEA (nausea) and ARTHRALGIA (joint aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 101 (Inconclusive) fever of 101 (degrees Fahrenheit)?.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: arm pain; total body aches; flu like symptoms; fever; nausea; joint aches; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (arm pain), PAIN (total body aches), INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever) and NAUSEA (nausea) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain), PAIN (total body aches), INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever), NAUSEA (nausea) and ARTHRALGIA (joint aches). At the time of the report, PAIN IN EXTREMITY (arm pain), PAIN (total body aches), INFLUENZA LIKE ILLNESS (flu like symptoms), PYREXIA (fever), NAUSEA (nausea) and ARTHRALGIA (joint aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 101 (Inconclusive) fever of 101 (degrees Fahrenheit)?.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest discomfort, Myalgia, Nasal congestion, SARS-CoV-2 test
Clinical narrative: tested positive for COVID; stuffy nose; mild tightness in chest; muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID), NASAL CONGESTION (stuffy nose), CHEST DISCOMFORT (mild tightness in chest) and MYALGIA (muscle ache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Tremor and Hypercholesteremia (high cholesterol). Concurrent medical conditions included Allergy (pine straw), Drug allergy (sulfa drugs) and Low blood pressure.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced COVID-19 (tested positive for COVID), NASAL CONGESTION (stuffy nose), CHEST DISCOMFORT (mild tightness in chest) and MYALGIA (muscle ache). At the time of the report, COVID-19 (tested positive for COVID), NASAL CONGESTION (stuffy nose), CHEST DISCOMFORT (mild tightness in chest) and MYALGIA (muscle ache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Injection site erythema, Muscle swelling, Pruritus, Vaccination site pain
Clinical narrative: Itching; muscle swelling; Hot; Pain at injection (L); Red Circle; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at injection (L)), INJECTION SITE ERYTHEMA (Red Circle), PRURITUS (Itching), MUSCLE SWELLING (muscle swelling) and FEELING HOT (Hot) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection (L)) and INJECTION SITE ERYTHEMA (Red Circle). On 30-Jan-2021, the patient experienced PRURITUS (Itching), MUSCLE SWELLING (muscle swelling) and FEELING HOT (Hot). On 24-Jan-2021, VACCINATION SITE PAIN (Pain at injection (L)) and INJECTION SITE ERYTHEMA (Red Circle) had resolved. At the time of the report, PRURITUS (Itching), MUSCLE SWELLING (muscle swelling) and FEELING HOT (Hot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: chills; fever of 98.9 F; bodyaches; headache; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever of 98.9 F), MYALGIA (bodyaches), HEADACHE (headache) and ARTHRALGIA (joint pain) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Diabetes mellitus.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (fever of 98.9 F), MYALGIA (bodyaches), HEADACHE (headache) and ARTHRALGIA (joint pain). At the time of the report, CHILLS (chills), PYREXIA (fever of 98.9 F), MYALGIA (bodyaches), HEADACHE (headache) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: nose bleed; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose bleed) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced EPISTAXIS (nose bleed). At the time of the report, EPISTAXIS (nose bleed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain
Clinical narrative: Chills; Fatigue; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigue) and PAIN (Body Aches) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for an unknown indication.     No Medical History information was reported.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced CHILLS (Chills), FATIGUE (Fatigue) and PAIN (Body Aches). At the time of the report, CHILLS (Chills), FATIGUE (Fatigue) and PAIN (Body Aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Dizziness, Emergency care examination, Heart rate increased, Influenza like illness
Clinical narrative: Had to go to the emergency room; Flu like symptoms; Elevated heart rate; Increased blood pressure; Light headed/dizziness; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Elevated heart rate), BLOOD PRESSURE INCREASED (Increased blood pressure), DIZZINESS (Light headed/dizziness), INFLUENZA LIKE ILLNESS (Flu like symptoms) and EMERGENCY CARE EXAMINATION (Had to go to the emergency room) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced HEART RATE INCREASED (Elevated heart rate), BLOOD PRESSURE INCREASED (Increased blood pressure) and DIZZINESS (Light headed/dizziness). On 04-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On an unknown date, the patient experienced EMERGENCY CARE EXAMINATION (Had to go to the emergency room). At the time of the report, HEART RATE INCREASED (Elevated heart rate), BLOOD PRESSURE INCREASED (Increased blood pressure) and DIZZINESS (Light headed/dizziness) had resolved and INFLUENZA LIKE ILLNESS (Flu like symptoms) and EMERGENCY CARE EXAMINATION (Had to go to the emergency room) outcome was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Injection site erythema, Pruritus, Rash
Clinical narrative: dizzy; itching; rash all over; red and hot; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), PRURITUS (itching), RASH (rash all over) and INJECTION SITE ERYTHEMA (red and hot) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L2OA) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced DIZZINESS (dizzy), PRURITUS (itching), RASH (rash all over) and INJECTION SITE ERYTHEMA (red and hot). At the time of the report, DIZZINESS (dizzy), PRURITUS (itching), RASH (rash all over) and INJECTION SITE ERYTHEMA (red and hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dyspnoea, Fatigue, Headache
Clinical narrative: chills; headache; fatigue; cough; labored breathing/shortness of breath; swelling of the left lymph node; This spontaneous case was reported by an other and describes the occurrence of CHILLS (chills), HEADACHE (headache), FATIGUE (fatigue), COUGH (cough) and DYSPNOEA (labored breathing/shortness of breath) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced CHILLS (chills), HEADACHE (headache), FATIGUE (fatigue), COUGH (cough), DYSPNOEA (labored breathing/shortness of breath) and LYMPHADENOPATHY (swelling of the left lymph node). On 15-Feb-2021, CHILLS (chills), HEADACHE (headache), FATIGUE (fatigue) and LYMPHADENOPATHY (swelling of the left lymph node) outcome was unknown. At the time of the report, COUGH (cough) and DYSPNOEA (labored breathing/shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: chills; headache; fatigue; cough; labored breathing/shortness of breath; swelling of the left lymph node; This spontaneous case was reported by an other and describes the occurrence of CHILLS (chills), HEADACHE (headache), FATIGUE (fatigue), COUGH (cough) and DYSPNOEA (labored breathing/shortness of breath) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced CHILLS (chills), HEADACHE (headache), FATIGUE (fatigue), COUGH (cough), DYSPNOEA (labored breathing/shortness of breath) and LYMPHADENOPATHY (swelling of the left lymph node). On 15-Feb-2021, CHILLS (chills), HEADACHE (headache), FATIGUE (fatigue) and LYMPHADENOPATHY (swelling of the left lymph node) outcome was unknown. At the time of the report, COUGH (cough) and DYSPNOEA (labored breathing/shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Decreased appetite, Fatigue, Nausea, Rash macular
Clinical narrative: a blotchy rash on my torso; 2 hive-like blisters on my upper chest; no appetite; nausea; vomiting; I felt washed out; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (a blotchy rash on my torso), BLISTER (2 hive-like blisters on my upper chest), DECREASED APPETITE (no appetite), NAUSEA (nausea) and VOMITING (vomiting) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced RASH MACULAR (a blotchy rash on my torso), BLISTER (2 hive-like blisters on my upper chest), DECREASED APPETITE (no appetite), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (I felt washed out). At the time of the report, RASH MACULAR (a blotchy rash on my torso), BLISTER (2 hive-like blisters on my upper chest), DECREASED APPETITE (no appetite), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (I felt washed out) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: a blotchy rash on my torso; 2 hive-like blisters on my upper chest; no appetite; nausea; vomiting; I felt washed out; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (a blotchy rash on my torso), BLISTER (2 hive-like blisters on my upper chest), DECREASED APPETITE (no appetite), NAUSEA (nausea) and VOMITING (vomiting) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced RASH MACULAR (a blotchy rash on my torso), BLISTER (2 hive-like blisters on my upper chest), DECREASED APPETITE (no appetite), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (I felt washed out). At the time of the report, RASH MACULAR (a blotchy rash on my torso), BLISTER (2 hive-like blisters on my upper chest), DECREASED APPETITE (no appetite), NAUSEA (nausea), VOMITING (vomiting) and FATIGUE (I felt washed out) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Flu like symptoms; Swelling of the entire injection arm; Burning of the entire injection arm; itching of the entire injection arm; Redness of the entire injection arm; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE SWELLING (Swelling of the entire injection arm), VACCINATION SITE PAIN (Burning of the entire injection arm), VACCINATION SITE PRURITUS (itching of the entire injection arm) and VACCINATION SITE ERYTHEMA (Redness of the entire injection arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE SWELLING (Swelling of the entire injection arm), VACCINATION SITE PAIN (Burning of the entire injection arm), VACCINATION SITE PRURITUS (itching of the entire injection arm), VACCINATION SITE ERYTHEMA (Redness of the entire injection arm) and PYREXIA (Fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE SWELLING (Swelling of the entire injection arm), VACCINATION SITE PAIN (Burning of the entire injection arm), VACCINATION SITE PRURITUS (itching of the entire injection arm), VACCINATION SITE ERYTHEMA (Redness of the entire injection arm) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that forty-eight hours after receiving her first shot of vaccine, she developed swelling, burning, itching and redness of the entire injection arm. patient confirmed that she developed flu like symptoms twenty-four hours after the shot and fever that lasted for eight hours.  patient took benadryl, Tylenol, Advil and also went to urgent care, but that redness, burning and swelling are now mild.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Flu like symptoms; Swelling of the entire injection arm; Burning of the entire injection arm; itching of the entire injection arm; Redness of the entire injection arm; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE SWELLING (Swelling of the entire injection arm), VACCINATION SITE PAIN (Burning of the entire injection arm), VACCINATION SITE PRURITUS (itching of the entire injection arm) and VACCINATION SITE ERYTHEMA (Redness of the entire injection arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE SWELLING (Swelling of the entire injection arm), VACCINATION SITE PAIN (Burning of the entire injection arm), VACCINATION SITE PRURITUS (itching of the entire injection arm), VACCINATION SITE ERYTHEMA (Redness of the entire injection arm) and PYREXIA (Fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), VACCINATION SITE SWELLING (Swelling of the entire injection arm), VACCINATION SITE PAIN (Burning of the entire injection arm), VACCINATION SITE PRURITUS (itching of the entire injection arm), VACCINATION SITE ERYTHEMA (Redness of the entire injection arm) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that forty-eight hours after receiving her first shot of vaccine, she developed swelling, burning, itching and redness of the entire injection arm. patient confirmed that she developed flu like symptoms twenty-four hours after the shot and fever that lasted for eight hours.  patient took benadryl, Tylenol, Advil and also went to urgent care, but that redness, burning and swelling are now mild.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Heart rate increased, Lymphadenopathy
Clinical narrative: Vaccination site swelling; Headache; Fever; Swollen Glands in Throat; Achiness; Fatigue; Elevated Heart Rate; Shortness of Breath; Hardness; Injection site Hot Sensation; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Glands in Throat), PAIN (Achiness) and FATIGUE (Fatigue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026LZOA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included Blood Thinner for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced HEADACHE (Headache), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Glands in Throat), PAIN (Achiness), FATIGUE (Fatigue), HEART RATE INCREASED (Elevated Heart Rate), DYSPNOEA (Shortness of Breath), VACCINATION SITE INDURATION (Hardness) and VACCINATION SITE WARMTH (Injection site Hot Sensation). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Vaccination site swelling). At the time of the report, HEADACHE (Headache), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Glands in Throat), PAIN (Achiness), FATIGUE (Fatigue), HEART RATE INCREASED (Elevated Heart Rate), DYSPNOEA (Shortness of Breath), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE WARMTH (Injection site Hot Sensation) and VACCINATION SITE SWELLING (Vaccination site swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination site induration, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Vaccination site swelling; Headache; Fever; Swollen Glands in Throat; Achiness; Fatigue; Elevated Heart Rate; Shortness of Breath; Hardness; Injection site Hot Sensation; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Glands in Throat), PAIN (Achiness) and FATIGUE (Fatigue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026LZOA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included Blood Thinner for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced HEADACHE (Headache), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Glands in Throat), PAIN (Achiness), FATIGUE (Fatigue), HEART RATE INCREASED (Elevated Heart Rate), DYSPNOEA (Shortness of Breath), VACCINATION SITE INDURATION (Hardness) and VACCINATION SITE WARMTH (Injection site Hot Sensation). On an unknown date, the patient experienced VACCINATION SITE SWELLING (Vaccination site swelling). At the time of the report, HEADACHE (Headache), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Glands in Throat), PAIN (Achiness), FATIGUE (Fatigue), HEART RATE INCREASED (Elevated Heart Rate), DYSPNOEA (Shortness of Breath), VACCINATION SITE INDURATION (Hardness), VACCINATION SITE WARMTH (Injection site Hot Sensation) and VACCINATION SITE SWELLING (Vaccination site swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives all over her body; Itching; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives all over her body) and PRURITUS (Itching) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HYDROCHLOROTHIAZIDE), SIMVASTATIN and CITALOPRAM for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced URTICARIA (Hives all over her body) and PRURITUS (Itching). At the time of the report, URTICARIA (Hives all over her body) and PRURITUS (Itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chills, Cough, Fatigue
Clinical narrative: Fever or Chills  Cough  Fatigue  Headache  New loss of taste or smell  Sore throat  Congestion or running nose  Nausea or vomiting
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Oropharyngeal pain, Pyrexia, Respiratory tract congestion
Clinical narrative: Fever or Chills  Cough  Fatigue  Headache  New loss of taste or smell  Sore throat  Congestion or running nose  Nausea or vomiting
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, Vomiting
Clinical narrative: Fever or Chills  Cough  Fatigue  Headache  New loss of taste or smell  Sore throat  Congestion or running nose  Nausea or vomiting
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Frustration tolerance decreased, Joint swelling, Memory impairment
Clinical narrative: Tightness in muscles. Lasting 5 days. Inner elbow, Severe pain to touch. Continuous to date. Visible swollen tendon. Massage and stretching reduced swelling, pain persists. Swelling returns periodically. Left Forearm muscles ache mildly, but continuous. Ache in shoulder. Stretching feels better, pain returns within hours. Left Clavicle discomfort. Continuous dull, occasional sharp. Outer elbow pain. Radiating pain is occasional. Wrist pain, near thumb.   Brain fog. Noticeable delayed verbal response. Failure to Connect memory to speach is really disruptive and frustrating.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle tightness, Musculoskeletal discomfort, Myalgia, Pain, Speech disorder developmental
Clinical narrative: Tightness in muscles. Lasting 5 days. Inner elbow, Severe pain to touch. Continuous to date. Visible swollen tendon. Massage and stretching reduced swelling, pain persists. Swelling returns periodically. Left Forearm muscles ache mildly, but continuous. Ache in shoulder. Stretching feels better, pain returns within hours. Left Clavicle discomfort. Continuous dull, occasional sharp. Outer elbow pain. Radiating pain is occasional. Wrist pain, near thumb.   Brain fog. Noticeable delayed verbal response. Failure to Connect memory to speach is really disruptive and frustrating.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Tendonitis
Clinical narrative: Tightness in muscles. Lasting 5 days. Inner elbow, Severe pain to touch. Continuous to date. Visible swollen tendon. Massage and stretching reduced swelling, pain persists. Swelling returns periodically. Left Forearm muscles ache mildly, but continuous. Ache in shoulder. Stretching feels better, pain returns within hours. Left Clavicle discomfort. Continuous dull, occasional sharp. Outer elbow pain. Radiating pain is occasional. Wrist pain, near thumb.   Brain fog. Noticeable delayed verbal response. Failure to Connect memory to speach is really disruptive and frustrating.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, Chest pain, Laboratory test normal, Pain, Painful respiration
Clinical narrative: patient started with chest pain prior to ER visit, substernal, worse with breathing and leaning forward. Also with fever.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Red blood cell sedimentation rate increased
Clinical narrative: patient started with chest pain prior to ER visit, substernal, worse with breathing and leaning forward. Also with fever.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, SARS-CoV-2 test
Clinical narrative: Fatigue
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Decreased appetite, Diarrhoea, Dyspnoea
Clinical narrative: Cough Diarrhea,  post-nasal drip,  fatigue,  decreased appetite,  chills Shortness of breath
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, SARS-CoV-2 test, Upper-airway cough syndrome
Clinical narrative: Cough Diarrhea,  post-nasal drip,  fatigue,  decreased appetite,  chills Shortness of breath